Have you been diagnosed with non-small cell lung cancer? Have you already been treated with an anti PDL-1 therapy and chemotherapy? If so, you may be able to take part in a research study looking to compare the safety and effectiveness of the investigational drug RMC-6236 to docetaxel.

You can help us change the way we treat overactive bladder. Right now, 60 million people in the U.S. deal with this condition, and treatments don't work the same for everyone. We think mental health, mood, and sleep might play a role, and we need your help to figure it out! All you need to do is answer some quick questions about your bladder, mood, and sleep before treatment starts and once more 2-4 months later. Your input could show us how improving mental well-being could make overactive bladder treatments work better.

Do you identify as Hispanic? Do you regularly buy beverages for your household? If so, you may be eligible to participate in a research study about what makes people decide to buy things in a convenience store. Compensation provided.

Are you interested in learning about your sleep, satiety, energy, and cognition? Interested in protein? You may be able to participate in a research study to find out how a plant-based protein, creatine, and fiber supplement may impact those outcomes.

Do you have moderate to severe plaque psoriasis? If so, you may qualify for a clinical research study evaluating an investigational treatment for plaque psoriasis.

Do you have Crohn's disease and painful period cramps? You may be able to join a research study. We want to learn which pain medicine works best and is safest for people with Crohn's disease.

Are you a Korean speaker living in the U.S. who has used a medical interpreter in a hospital? We are conducting a study to learn about your communication experiences with interpreters and healthcare providers. You can choose to complete a short online survey or participate in a one-on-one interview in Korean. You may enter a drawing based on chance in which each participant has equal odds of receiving the incentive for the survey and receive a gift card for participating in the interview. The study has been modified to broaden the survey participant criteria to include individuals who have not used medical interpreter services, in addition to those who have.

Do you have epilepsy and wish that exercise programs actually fit your needs? If you are diagnosed with epilepsy, are 18 years or older, and live in the United States, you may be able to participate in a research study by completing a brief, anonymous online survey about your exercise preferences and what helps or makes it harder to stay active as a person with epilepsy. You could also enter a drawing to win one of five, $50 Amazon gift cards with an equal probability of winning.

Are you living with primary biliary cholangitis (PBC) and are taking or plan to take elafibranor for your condition? Consider joining our registry study to help advance treatment options and patient quality of life with this condition. We invite you to participate to discuss your experience and the impact on your condition seen with elafibranor. By joining, you'll contribute to understanding the effectiveness and safety of elafibranor in treating PBC. The study aims to evaluate its impact on itching, fatigue, sleep, and overall quality of life. Your participation is voluntary, and you can withdraw at any time without losing medical benefits. With approximately 424 participants globally, you'll continue to receive treatment as usual during the 5-year study period. Plus, you'll have opportunities to discuss your experience with our team and have your voice heard regarding your experience with elafibranor and it's effect on your quality of life with PBC.

Are you tired of answering the usual questions about things like gender, race, and income on surveys? We need your help! We want to make these questions better to understand everyone's health needs in the U.S. Participating is easy and helps improve the way we ask these important questions. Interested? Join us today!